Just what the doctor ordered
The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon
December 23, 2017
Nursing Back to Health
A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players
Jash Kriplani - October 18, 2017
Bold and Bountiful
Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics
Kripa Mahalingam - July 11, 2017
A Bitter Pill
Regulatory woes continue to pile up for pharma companies
Kripa Mahalingam - May 12, 2017
A new prescription
Tectonic changes in the US generic drugs market is causing huge shifts in Indian pharma’s strategies as well
Team Outlook Business - December 17, 2015